-
Product Insights
Pegasus Bedford Solar PV Park
Pegasus Bedford Solar PV Park profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation, year online, decommissioning year, capital expenditure etc. Details on project specific contacts along with relevant news, deals and contracts are also provided through the plant profile. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the...
-
Product Insights
Pegasus Group – Plymouth Moneycentre Building Redevelopment – Plymouth
Equip yourself with the essential tools needed to make informed and profitable decisions with our Pegasus Group - Plymouth Moneycentre Building Redevelopment - Plymouth report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Pegasus Plng – Onslow Road Residential Community – Gloucestershire
Equip yourself with the essential tools needed to make informed and profitable decisions with our Pegasus Plng - Onslow Road Residential Community - Gloucestershire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Pegasus Plng – Highgate Residential Community – City and Borough of Birmingham
Equip yourself with the essential tools needed to make informed and profitable decisions with our Pegasus Plng - Highgate Residential Community - City and Borough of Birmingham report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
51 Pegasus – St Albans Hilton Doubletree Hotel – Hertfordshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our 51 Pegasus - St Albans Hilton Doubletree Hotel - Hertfordshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Pegasus Plng – Calder Park Storage and Distribution facility – City and Borough of Wakefield
Equip yourself with the essential tools needed to make informed and profitable decisions with our Pegasus Plng - Calder Park Storage and Distribution facility - City and Borough of Wakefield report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
HFZ Capital/ Pegasus Cap – The XI Mixed-Use Complex – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our HFZ Capital/ Pegasus Cap - The XI Mixed-Use Complex - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Pegasus Part – 1200 Madison Street Mixed-Use Development – New Jersey
Equip yourself with the essential tools needed to make informed and profitable decisions with our Pegasus Part - 1200 Madison Street Mixed-Use Development - New Jersey report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KT-333 in Cutaneous T-Cell Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.KT-333 in Cutaneous T-Cell Lymphoma Drug Details:KT-333 is under development for the treatment of peripheral T...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KT-333 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.KT-333 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drug Details:KT-333 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KT-333 in Natural Killer Cell Lymphomas
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.KT-333 in Natural Killer Cell Lymphomas Drug Details:KT-333 is under development for the treatment of peripheral...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KT-333 in Non-Hodgkin Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.KT-333 in Non-Hodgkin Lymphoma Drug Details:KT-333 is under development for the treatment of peripheral T cell...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KT-333 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.KT-333 in Solid Tumor Drug Details:KT-333 is under development for the treatment of peripheral T cell...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KT-333 in Peripheral T-Cell Lymphomas (PTCL)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.KT-333 in Peripheral T-Cell Lymphomas (PTCL) Drug Details:KT-333 is under development for the treatment of peripheral...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KT-333 in T-Cell Lymphomas
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.KT-333 in T-Cell Lymphomas Drug Details:KT-333 is under development for the treatment of peripheral T cell...
-
Product Insights
Pegasus Field, United States
Each upstream field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and capital and operating costs. We also provide proprietary forecasts of production, capital and operating costs, and other key economic parameters, along-with relevant news, deals and contracts details. This is an on-demand report that will be delivered upon request. The report...
-
Product Insights
Pegasus Medical Concepts Inc, United States Revenue
GlobalData, the industry analysis specialist, has released its latest report: Pegasus Medical Concepts Inc, United States Revenue. The medical devices sector is typified by frequent change and innovation in available devices, in response to demand from healthcare for ever more effective therapies and increased competition. As a result, the sector has seen the emergence of start-up medtech companies who are producing the most innovative and cutting-edge solutions to problems and issues faced by the healthcare industry. Most of these companies...
-
Company Profile
![]()
Kymera Therapeutics Inc – Company Profile
Kymera Therapeutics Inc (Kymera) is a clinical stage biopharma and technology company involved in developing small molecule therapeutics for protein degradation. The companiy's pipeline product portfolio comprise IRAK4, IRAKIMiD, STAT3 and MDM2. Its targeted protein degradation platform Pegasus, an information technology powered platform that allows the discovery of selective small molecule protein degraders against disease-causing proteins throughout the body. The company also carries out research and discovery of breakthrough drugs addressing novel medical areas. Its product find application in cancers,...
Add to Basket -
Thematic Analysis
![]()
Mergers and Acquisitions in Tech, Media, and Telecom (TMT) 2022 Themes – Thematic Intelligence
M&A in TMT Thematic Report Overview In 2022, the major themes that impacted the M&A sector in the technology, media, and telecom (TMT) industry were mainly categorized into four segments- hardware, software and services, internet & media, and telecom services. M&A activity in the global TMT sector has been increasing since 2018, but the trend reversed in 2022. In 2022, the software and services sector accounted for more than 57% of the overall TMT M&A deal value. The Mergers and...
-
Thematic Analysis
![]()
Tech, Media and Telecom (TMT) Industry M&A Deals by Top Themes in 2022 – Thematic Intelligence
Tech, Media and Telecom Industry Mergers and Acquisitions Deals Report Overview The tech, media and telecom (TMT) sector witnessed 11,048 M&A deals worth $841 billion in 2022. North America lead the M&A activity in 2022. The top themes driving M&A activity in the TMT sector in 2022 were cloud and cybersecurity, while the internet & media sector was driven by internet advertising and digital media. The tech, media and telecom industry M&A deals thematic intelligence report provides an overview of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.